John A. DeSisto

This study uses multi-omics approaches to analyze pediatric low-grade glioma and identifies immune-related differences linked to BRAF mutations.

This paper identifies CD99 as a therapeutic target in K27M+DMGs, showing that a novel anti-CD99 antibody reduces tumor growth and enhances radiation efficacy in preclinical models.

This study examines how microbubble size, composition, and sonication points affect blood-brain barrier opening and sterile inflammatory response in mice.

This study identifies PRMT5 as essential for pediatric high-grade glioma growth by maintaining tumor stem cells, showing that its inhibition reduces self-renewal and improves survival in preclinical models.

This study creates a cellular atlas of developing meningeal fibroblasts in mice and humans, revealing distinct subtypes and their functional roles in CNS development.